Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug

Detalles Bibliográficos
Autor principal: Rabie, Amgad M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Versita 2022
Materias:
Retraction Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166213/
https://www.ncbi.nlm.nih.gov/pubmed/35692492
http://dx.doi.org/10.1007/s11696-022-02315-9
_version_ 1784720555974328320
author Rabie, Amgad M.
author_facet Rabie, Amgad M.
author_sort Rabie, Amgad M.
collection PubMed
description
format Online
Article
Text
id pubmed-9166213
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Versita
record_format MEDLINE/PubMed
spelling pubmed-91662132022-06-07 Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug Rabie, Amgad M. Chem Zvesti Retraction Note Versita 2022-06-04 2022 /pmc/articles/PMC9166213/ /pubmed/35692492 http://dx.doi.org/10.1007/s11696-022-02315-9 Text en © Institute of Chemistry, Slovak Academy of Sciences 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Retraction Note
Rabie, Amgad M.
Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title_full Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title_fullStr Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title_full_unstemmed Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title_short Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
title_sort retraction note to: discovery of (e)-n-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-covid-19 drug
topic Retraction Note
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166213/
https://www.ncbi.nlm.nih.gov/pubmed/35692492
http://dx.doi.org/10.1007/s11696-022-02315-9
work_keys_str_mv AT rabieamgadm retractionnotetodiscoveryofen4cyanobenzylidene6fluoro3hydroxypyrazine2carboxamidecyanorona20thefirstpotentandspecificanticovid19drug

Ejemplares similares